TP53 and cancer: A systemic evaluation of current genomic sequencing and proteomic data in UC of the UUT confirmed molecular differences in FGFR3 (fibroblast growth receptor 3), TP53, and MSI between sporadic (80–90%) and hereditary (10–20%) UUT cancers.